462 related articles for article (PubMed ID: 31732967)
1. MiR-29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1.
Wang R; Yang Y; Wang H; He Y; Li C
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):372-382. PubMed ID: 31732967
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.
Yao L; Ye Y; Mao H; Lu F; He X; Lu G; Zhang S
J Neuroinflammation; 2018 Jan; 15(1):13. PubMed ID: 29329581
[TBL] [Abstract][Full Text] [Related]
3. miR-29c-3p regulates TET2 expression and inhibits autophagy process in Parkinson's disease models.
Wang R; Yao J; Gong F; Chen S; He Y; Hu C; Li C
Genes Cells; 2021 Sep; 26(9):684-697. PubMed ID: 34086379
[TBL] [Abstract][Full Text] [Related]
4. LINC00943 acts as miR-338-3p sponge to promote MPP
Sun X; Zhang C; Tao H; Yao S; Wu X
Brain Res; 2022 May; 1782():147814. PubMed ID: 35123924
[TBL] [Abstract][Full Text] [Related]
5. Achyranthes bidentata polypeptide protects dopaminergic neurons from apoptosis in Parkinson's disease models both in vitro and in vivo.
Peng S; Wang C; Ma J; Jiang K; Jiang Y; Gu X; Sun C
Br J Pharmacol; 2018 Feb; 175(4):631-643. PubMed ID: 29181847
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation.
Peng T; Liu X; Wang J; Liu Y; Fu Z; Ma X; Li J; Sun G; Ji Y; Lu J; Wan W; Lu H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2764-2774. PubMed ID: 31298038
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of transcription factor SP1 produces neuroprotective effects through decreasing MAO B activity in MPTP/MPP
Yao L; Dai X; Sun Y; Wang Y; Yang Q; Chen X; Liu Y; Zhang L; Xie W; Liu J
J Neurosci Res; 2018 Oct; 96(10):1663-1676. PubMed ID: 30004136
[TBL] [Abstract][Full Text] [Related]
8. Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.
Su C; Yang X; Lou J
Brain Res; 2016 Aug; 1644():98-106. PubMed ID: 27173998
[TBL] [Abstract][Full Text] [Related]
9. miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.
Geng L; Zhang T; Liu W; Chen Y
Neurosci Lett; 2018 May; 675():23-30. PubMed ID: 29567426
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.
Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y
J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOTAIR promotes α-synuclein aggregation and apoptosis of SH-SY5Y cells by regulating miR-221-3p in Parkinson's disease.
Sun Q; Zhang Y; Wang S; Yang F; Cai H; Xing Y; Zhou L; Chen S; Wang Y
Exp Cell Res; 2022 Aug; 417(1):113132. PubMed ID: 35398161
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells.
Chen Y; Lian YJ; Ma YQ; Wu CJ; Zheng YK; Xie NC
Neurotoxicology; 2018 Sep; 68():212-221. PubMed ID: 29217406
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3.
Li D; Yang H; Ma J; Luo S; Chen S; Gu Q
Hum Cell; 2018 Apr; 31(2):106-115. PubMed ID: 29274035
[TBL] [Abstract][Full Text] [Related]
14. miR-101a-3p/ROCK2 axis regulates neuronal injury in Parkinson's disease models.
Tao X; Zhang W; Chen C; Tao Y; Tao Y; Chen Z; Zhang G
Aging (Albany NY); 2024 May; 16(10):8732-8746. PubMed ID: 38775730
[TBL] [Abstract][Full Text] [Related]
15. MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway.
Ge H; Yan Z; Zhu H; Zhao H
Exp Mol Pathol; 2019 Aug; 109():16-24. PubMed ID: 31067440
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
[TBL] [Abstract][Full Text] [Related]
17. miR-126-5p Targets SP1 to Inhibit the Progression of Parkinson's Disease.
Han YP; Liu ZJ; Bao HH; Wang Q; Su LL
Eur Neurol; 2022; 85(3):235-244. PubMed ID: 35108712
[TBL] [Abstract][Full Text] [Related]
18. Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson's disease.
Li J; Chen L; Qin Q; Wang D; Zhao J; Gao H; Yuan X; Zhang J; Zou Y; Mao Z; Xiong Y; Min Z; Yan M; Wang CY; Xue Z
Neurobiol Dis; 2022 Feb; 163():105605. PubMed ID: 34973450
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA NEAT1 mediates the toxic of Parkinson's disease induced by MPTP/MPP+ via regulation of gene expression.
Liu Y; Lu Z
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):841-848. PubMed ID: 29575151
[TBL] [Abstract][Full Text] [Related]
20. Early B Cell Factor 3 (EBF3) attenuates Parkinson's disease through directly regulating contactin-associated protein-like 4 (CNTNAP4) transcription: An experimental study.
Hu W; Wang M; Sun G; Zhang L; Lu H
Cell Signal; 2024 Jun; 118():111139. PubMed ID: 38479556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]